Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2005-12-14 (20 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: ROBION (84440), Vaucluse
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DES MARRONNIERS : revenue, balance sheet and financial ratios
PHARMACIE DES MARRONNIERS is a French company
founded 20 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in ROBION (84440),
this company of category PME
shows in 2024 a net income positive of 179 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DES MARRONNIERS (SIREN 487526824)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
178 591 €
183 773 €
298 674 €
361 202 €
197 786 €
146 454 €
135 734 €
136 353 €
173 384 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE DES MARRONNIERS generates positive net income of 179 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 173 k€ -> 179 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
178 591 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 47%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 59%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
46.944%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
59.259%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DES MARRONNIERS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
44.106
61.314
321.774
237.2
172.701
113.019
72.05
61.909
46.944
Financial autonomy
50.038
54.56
21.021
26.268
32.236
41.076
49.68
52.341
59.259
Repayment capacity
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
46.942024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Good-6 pts over 3 years
In 2024, the debt ratio of PHARMACIE DES MARRONNIERS (46.94) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
59.26%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good+9 pts over 3 years
In 2024, the financial autonomy of PHARMACIE DES MARRONNIERS (59.3%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 218.05. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
218.05
Liquidity indicators evolution PHARMACIE DES MARRONNIERS
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
243.766
215.39
214.474
202.991
201.989
229.792
185.646
189.957
218.05
Interest coverage
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
218.052024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Good+18 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE DES MARRONNIERS (218.05) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of PHARMACIE DES MARRONNIERS in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DES MARRONNIERS is estimated at
2 493 262 €
(range 1 736 268€ - 3 730 063€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1736k€2493k€3730k€
2 493 262 €Range: 1 736 268€ - 3 730 063€
NAF 5 année 2024
Valuation method used
Net Income Multiple
178 591 €
×
14.0x
=2 493 262 €
Range: 1 736 269€ - 3 730 063€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DES MARRONNIERS with other companies in the same sector:
Frequently asked questions about PHARMACIE DES MARRONNIERS
What is the revenue of PHARMACIE DES MARRONNIERS ?
The revenue of PHARMACIE DES MARRONNIERS is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DES MARRONNIERS profitable?
Yes, PHARMACIE DES MARRONNIERS generated a net profit of 179 k€ in 2024.
Where is the headquarters of PHARMACIE DES MARRONNIERS ?
The headquarters of PHARMACIE DES MARRONNIERS is located in ROBION (84440), in the department Vaucluse.
Where to find the tax return of PHARMACIE DES MARRONNIERS ?
The tax return of PHARMACIE DES MARRONNIERS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DES MARRONNIERS operate?
PHARMACIE DES MARRONNIERS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart